Related Experiment Video
Updated: Jun 4, 2025
11:28
Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
18.0K
Nitric oxide modelling and its bioavailability influenced by red blood cells
Ananta Kumar Nayak1, Marco Canepari1, Sovan Lal Das2
1Université Grenoble Alpes, CNRS, LIPhy, Grenoble 38000, France.
Journal of the Royal Society, Interface
|December 18, 2024
Summary
Increased red blood cell (RBC) concentration raises ATP and Ca2+ but lowers nitric oxide (NO) levels, impacting NO bioavailability, especially in narrow vessels.
Area of Science:
- Computational fluid dynamics
- Biomedical engineering
- Physiology
Background:
- Nitric oxide (NO) is crucial for maintaining vascular tone and is produced in endothelial cells (ECs).
- NO production is regulated by cytoplasmic Ca2+ and shear stress, influenced by adenosine triphosphate (ATP) from red blood cells (RBCs).
- RBCs can also scavenge NO, affecting its bioavailability.
Purpose of the Study:
- To model ATP and shear stress-dependent NO production, integrating biochemical pathways.
- To investigate the impact of RBC concentration, flow, and vessel geometry on NO bioavailability.
- To understand spatial variations in NO dynamics within blood circulation.
Main Methods:
- Development of a computational model incorporating ATP and shear stress-dependent NO production.
- Utilized the immersed boundary lattice Boltzmann method for simulating RBC flow, ATP release, and NO dynamics.
- Analysis conducted in a two-dimensional channel with varying vessel widths and RBC concentrations.
Main Results:
- Elevated RBC concentration increased ATP and cytoplasmic Ca2+ but decreased NO concentration across all channel widths.
- NO bioavailability was significantly affected by RBC distribution, particularly in confined channels.
- Two distinct phases of NO bioavailability were observed: significant changes at low RBC concentration and minimal changes at high RBC concentration.
Conclusions:
- RBC concentration and distribution are critical determinants of NO bioavailability.
- Vessel confinement and flow conditions modulate NO dynamics.
- Findings offer insights into NO-dependent vasodilation and oxygen transport in microvascular networks.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
01:23Antihypertensive Drugs: Vasodilators
474
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
474
00:57Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
62
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
62
01:16Antianginal Drugs: Nitrates and β-Blockers
517
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
517
01:13Bioavailability: Overview
2.7K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.7K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K